Nephrology
-
Multicenter Study Comparative Study
Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Clinical outcomes of patients with end-stage kidney disease (ESKD) receiving renal replacement therapy (RRT) secondary to IgA nephropathy (IgAN) have not been well described. ⋯ IgAN ESKD was associated with better dialysis and renal transplant outcomes compared with other forms of ESKD. The survival outcomes of ESKD patients with HSPN were worse than kidney-limited IgAN.